UPCOMING SESSIONS in ET
Tue, May 26, 2026
5:00 – 6:00 AM Bangkok
Advocacy 101: Finding Your Voice & Speaking Up with Confidence Thomas Bartlett Click To Register
UPCOMING SESSIONS in ET
Tue, May 26, 2026 · 5:00 – 6:00 AM Bangkok
Advocacy 101: Finding Your Voice & Speaking Up with Confidence
Thomas Bartlett
Click To Register
View all sessions

FDA grants fast track status to Novo Nordisk’s ATTR-CM drug

Published: Apr 27, 2026
Category
News
Source
Investing

DUBLIN - The U.S. Food and Drug Administration has granted Fast Track Designation to coramitug, an investigational antibody for treating ATTR amyloidosis with cardiomyopathy, Prothena Corporation plc (NASDAQ:PRTA) announced today.

News Url
Read More